Navigation Links
Streamline Health to Announce Third Quarter of Fiscal Year 2008 Financial Results on Tuesday, December 2, 2008
Date:11/18/2008

CINCINNATI, Nov. 18 /PRNewswire-FirstCall/ -- Streamline Health Solutions, Inc. (Nasdaq: STRM) announced today that it will release third quarter of fiscal year 2008 financial results for the period ended October 31, 2008 on Tuesday, December 2, 2008 after the market closes. The Company will hold a conference call and web cast to discuss the results on Tuesday, December 2, at 4:30 p.m. ET.

Interested parties can access the call by dialing (877) 356-5706 or (706) 679-3820, or can listen via a live Internet web cast, which can be found at http://www.streamlinehealth.net. A replay of the call will be available by visiting http://www.streamlinehealth.net for 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 70446458, through December 5, 2008.

About Streamline Health Solutions, Inc.

Streamline Health is a leading supplier of workflow and document management tools, applications and services that assist strategic business partners and healthcare organizations to improve operational efficiencies through business process optimization. The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, portal connectivity, optical character recognition (OCR) and interoperability.

The Company's workflow-based services offer solutions to inefficient and labor-intensive healthcare business processes throughout the revenue cycle, such as chart coding, abstracting and completion, remote physician order processing, pre-admission registration scanning and signature capture, insurance verification, secondary billing services, explanation of benefits processing and release of informa
'/>"/>

SOURCE Streamline Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
2. American Medical Association Endorses CAQH CORE Effort to Standardize and Streamline Patient Administrative Data Exchange
3. WILLCARE Chooses Authentidates Inscrybe(TM) Healthcare Service to Streamline Operations and Enhance Business Growth
4. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
5. Swiss Medical Group Selects ILog JRules to Streamline Claims Processing
6. Streamline Health(R) Announces Agreement with The Health Alliance of Greater Cincinnati for Hosted Document Workflow Solutions
7. Streamline Health(R) Signs Catholic Healthcare West for Integrated Document Workflow Solutions
8. Healthfirst and MD On-Line Partner to Streamline Claims Processing
9. Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office
10. Rioja Hospital Uses TIBCO Software to Improve Customer Care and Streamline Operations
11. Streamline Healths Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients Information - Either Scanned or Electronic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...AAF Urge State Leaders to Support Principles to Go...lif., July 2 Nearly nin...rance companies have too much influence over how d...e (80%) voters support the concept of a "Health In... of guiding principles for health insurance compan...
(Date:7/2/2009)...SILVER, N.J., July 2 Dr Daniel Gol...rdinating a new study to measure the effectiveness...acute EKC -- a common, worldwide, highly contagiou... potential for long term visual impairment due to ...d the world are invited to register to participate...
(Date:7/2/2009)...res weight problems faced by youngsters with the d...ews) -- Children with type 1 diabetes are more lik...e, increasing their risk of serious health complic...a major study that explored the weight problems fa...s common form of the disease that usually shows up...
(Date:7/2/2009)...K, July 2 Tuesday night saw the la...cert in Barcelona where U2 kicked off their new to..., , (RED)ZONES are prime location areas directl...ughout the U2 tour. The tickets for the (RED)ZONE...rtion of the ticket sales going to the Global Fund...
Breaking Medicine News(10 mins):Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2Health News:Kids With Type 1 Diabetes Often Overweight 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 3
...s children below the age of three are underweight ... bed hungry every day, says new data.// The Natio... Food Programme (WFP) say 45.9 percent of Indian c...erweight - they do not meet the standard weight in...
...r are quite frustrated by the large number of stra...cases// recorded by the main SMHS hospital here la...the last two months. 'The situation is alarming. W...y day. In some cases the victims are suspected to ...
...a pronounced risk of suffering weak bones due to t... Therefore, physicians need to be vigilant to spot...ording to the report the mix of sedentary behavior...allout of cancer, could result in suppression of b...
...CORT? for asthma provides a rapid and clinically s...t// in lung function within 15 minutes after admin...that in comparison to its monocomponents (budesoni...ORT and the other treatment groups containing form...
Other Medicine News:Health News:Bone Fragility, a Risk for Children With Cancer 2Health News:New Data Shows Significant Asthma Control With Symbicort 2
(Date:7/3/2009)... , TURKU, Finland, July 3 B...ent company with its headquarters in Turku, Finlan...clinical trial of ProtoCure(TM),emulsion cream, t...his,double-blind, placebo-controlled study, condu...o moderate atopic dermatitis who applied the Proto...
(Date:7/1/2009)... , REYKJAVIK, Iceland, July 1 /PRNewswire-F... schizophrenia ever undertaken has revealed severa...ce of the human genome (SNPs) linked to,risk of t...um of scientists,led by a team from deCODE geneti... than 50,000 patients and control participants fro...
(Date:6/30/2009)... , SAN DIEGO, June 30 Accumetri... mark (1,600 patients) in the enrollment of its la...nsiveness with A V erifyNow(R) Assay I mpact on ...ically designed to demonstrate the value of provid...ients who are poor responders to clopidogrel (Plav...
(Date:6/29/2009)... , Prospective Study Seeks to Assess RSV Burden...Reinforcing Commitment to Pediatric Research , ...Immune continues to advance its commitment to pedi...rst observational prospective study designed to as...V) among preterm infants 32-to-35 weeks gestationa...
Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 1Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 2Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 3Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 4Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 5Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 6Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 7Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 8Exjade 28R 29 Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs According to Landmark Trial 31624 9Align Technology Receives Expanded Regulatory Approval in Japan 9567 1Align Technology Receives Expanded Regulatory Approval in Japan 9567 2Quantros Acquires MEDMARX 28R 29 from United States Pharmacopeia 28USP 29 9565 1Quantros Acquires MEDMARX 28R 29 from United States Pharmacopeia 28USP 29 9565 2Quantros Acquires MEDMARX 28R 29 from United States Pharmacopeia 28USP 29 9565 3Quantros Acquires MEDMARX 28R 29 from United States Pharmacopeia 28USP 29 9565 4AstraZeneca and Targacept Announce Top Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia 3593 1AstraZeneca and Targacept Announce Top Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia 3593 2AstraZeneca and Targacept Announce Top Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia 3593 3AstraZeneca and Targacept Announce Top Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia 3593 4
... - Neurologix, Inc.,(OTCBB:NRGX) today announced t... The Lancet of positive results from the first eve...he first report of,direct gene transfer into a pat...tive disease., The open label Phase 1 study, condu...ase demonstrated both a lack of adverse,events rel...
...- The,PromegaExpress(TM) on-site stocking program ...ne of on-site appliances. This,latest addition ser...ry requirements for smaller areas when space is at...ols is a necessity. The,mid-sized cabinet can also... freezer component., The entire line (see attached...
Other Medicine Technology:Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, s
The eNclose Anastomosis Assist Device was designed specifically to obviate the need for partial clamping of the aorta. The enclose device can provide the surgeon with a stable, bloodless field and im
15mm Open Blades, 30mm Maximum Blade Spread; in Titanium.
7mm Cross Hairs; Available in 4.5mm to 7.0mm in 0.5mm increments; Ring depth available from 2 to 4mm in 0.5mm increments.; in stainless steel.
Medicine Products: